Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-15-059838

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ANDREWS DEBORAH J · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-07-01 Grant or award : show line 1 in the form Option to Purchase Common Shares +20,000 $3.57 2020-06-30 20,000 20,000 D
Loading xslF345X03/doc4.xml…